| Literature DB >> 9153311 |
A Garbesi1, S Bonazzi, S Zanella, M L Capobianco, G Giannini, F Arcamone.
Abstract
Conjugation of an anthracycline to a triplex-forming oligonucleotide (TFO) allows delivery of this drug to a specific DNA site, preserving the intercalation geometry of this class of anticancer agents. Conjugate 11, in which the TFO is linked via a hexamethylene bridge to the O-4 on the D ring of the anthraquinone moiety, affords the most stable triple helix, through intercalation of the planar chromophore between DNA bases and binding of both the TFO and the amino sugar to the major and the minor groove respectively.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9153311 PMCID: PMC146708 DOI: 10.1093/nar/25.11.2121
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971